“Surge in prevalence of infectious diseases across the globe is anticipated to significantly drive the growth of the IVD Industry. Furthermore, cost-effective diagnostic solutions is the key factor that augments the market growth.”
The global in vitro diagnostics (IVD) market generated $64.5 billion in 2017 and is expected to garner $93.6 billion by 2025, registering a CAGR of 4.8% during the forecast period, 2018-2025.
The growth of the global in vitro diagnostics (IVD) market is driven by rise in incidences of chronic and infectious diseases worldwide, emergence of minimally invasive technologies, increase in popularity of personalized medicine, and technological advancements in IVD. Additionally, potential opportunities for outsourcing and convergence of new technologies is set to provide lucrative opportunities to emerging market players in the near future. However, strict regulatory policies and uncertainty in reimbursement policies restrict market growth.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/336
The report segments the global in vitro diagnostics (IVD) market based on product type, techniques, application, end user, and geography. By product type, the report segregates the market into reagents, instruments, and software & services. The reagents segment accounted for the highest market share in 2017 due to a large number of reagents introduced in the market for the diagnosis of medical conditions using IVD process. However, the instruments segment is anticipated to grow with the highest CAGR throughout the forecast period.
By techniques, the market is sub-segmented into immunodiagnostics, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. The immunodiagnostics segment contributed the highest market share in 2017 due to the increase in usage of immunodiagnostics as these tests are the oldest and highly used techniques for the diagnosis infectious diseases, oncology detection, HIV/AIDS virus detection, and others. By end user, the market is categorized into standalone laboratory, hospitals, academic & medical schools, point of care testing, and others.
By application, the report divides the market into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. The infectious diseases segment contributed the highest market share in 2017 due to increase in prevalence of infectious diseases and rise in awareness of preventive health measures. Regionally, North America occupied nearly one-third of the global market in 2017 and is expected to continue its dominance through 2025. This is attributed to a well-established healthcare system and higher healthcare awareness among the patients.
The key players analyzed in the report include:
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMrieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- QIAGEN N.V.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
They have adopted various strategies such as mergers & acquisitions, collaborations, partnerships, and others to gain a strong position in the industry.
Key Findings of the In Vitro Diagnostics Market:
- North America occupied nearly one-thirds share of the global IVD market in 2017.
- The instruments segment is anticipated to grow with the highest CAGR throughout the forecast period.
- The immunodiagnostics segment accounted for around one-third share of the global IVD market in 2017.
- Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Scope of the Report
| Report Attribute | Details |
| Market size available for years | 2018-2025 |
| Base year considered | 2019 |
| Forecast period | 2019-2025 |
| Forecast units | Value (USD) |
| Segments covered | Type, Technique, Application and End User |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
Related Report
France IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) – Opportunity Analysis and Industry Forecast, 2017-2023
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3600
U.S. IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) – Opportunity Analysis and Industry Forecast, 2017-2023
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3817
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Read More @ https://www.alliedmarketresearch.com/press-release/ivd-in-vitro-diagnostics-market.html
